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Diabetic retinopathy is a leading cause of blindness in people in
the working age group in developing and developed countries,
and screening for retinopathy forms part of the strategy to
reduce the morbidity associated with diabetes mellitus.1
Within the African context, shortages of medical personnel,
funding and facilities make it imperative that these scarce
resources are utilised optimally. Screening for diabetic
retinopathy has been performed by several different kinds of
health care personnel, including general practitioners and
optometrists,1 and dilated mydriatic colour fundus photography
is currently regarded as the most effective screening strategy.2
Screening using direct ophthalmoscopy has been shown to have
low sensitivity (65%) compared with photography (89%).3
Fundus photographs have the advantage that a trained
technician can do the screening and the photographs can later be
viewed and graded by a medically trained person or else
adequately graded by a technician.4 The patient’s photographs
can be compared with standard fundus photographs, such as the
Wisconsin set of standard photographs (http://eyephoto.
ophth.wisc.edu/). 
Complex and precise methods of grading retinopathy4 may be
required for research, but simpler classifications can facilitate
rapid screening. A recent attempt to achieve consensus on
common terminology also tried to produce a practicable method
for clinical assessment.5 The authors suggested three degrees of
non-proliferative retinopathy, viz. mild, moderate and severe, as
well as proliferative retinopathy. Maculopathy was graded
separately but can simply be classified as present or absent if the
severity of the maculopathy cannot be judged by the screening
person. Once common terminology has been established,
agreement might then be reached between screener and referral
ophthalmologist on what grades of retinopathy require referral
for treatment.
In South Africa, mydriatic fundus photography was found to
be superior to both photography without mydriasis and direct
ophthalmoscopy.6 At the diabetic clinic at Johannesburg
Hospital, 60° fundus photography was shown to compare well
with one or two overlapping 45° field assessments and also with
57
January 2005, Vol. 95, No. 1  SAMJ
Effective and accurate screening for diabetic retinopathy using a 60°
mydriatic fundus camera
T R Carmichael, G I Carp, N D Welsh, W J Kalk
Objectives. To establish whether an experienced endocrinologist
could screen accurately for diabetic retinopathy using mydriatic
60° fundus photographs compared with a reference standard,
viz. the combined highest scores of two experienced
ophthalmologists.  
Design. Retrospective review of 60° colour transparency
photographs taken over a 6-year period. Retinopathy was
graded in a standardised way.
Setting. Patients attending the diabetic clinic at Johannesburg
Hospital, South Africa.
Subjects. Fifteen hundred and seventeen patients (2 446 eyes)
formed the basis for the study. Patients were included if there
was more than 50% readability of the fundus photographs.
Outcome measures. Outcome measures were prevalence of any
retinopathy and presence of referable (severe) retinopathy. Inter-
observer agreement was measured using the kappa statistic,
and sensitivity and specificity of the screener were evaluated.
Results. The prevalence of retinopathy at the clinic was
approximately 30%, but only about 12% was severe enough
to warrant referral to the ophthalmology outpatient
department. The endocrinologist was very accurate in
determining cases requiring referral; there was 97%
agreement with the reference standard, viz. the combined
highest score of two experienced ophthalmologists (gold
standard). Correlation on the determination of any retino-
pathy was less accurate (80% agreement), mostly owing to
the endocrinologist reporting more isolated microaneurysms
than the ophthalmologists. The screening method used gave
a sensitivity of 83% and specificity of 99% which are within
recommended standards.
Conclusions. The screening strategy using a mydriatic fundus
camera at the diabetic clinic was found to be effective and
accurate and greatly reduced the number of possible
referrals to the ophthalmology outpatient department. 
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ophthalmologist screening.7 Some associations with diabetic
retinopathy at this clinic were later reported.8 Severe diabetic
retinopathy was found to be associated with African race group,
and this group showed poorer glycaemic control and more
systolic hypertension.
During the present study we tested the accuracy of the referral
system and in particular established whether the
endocrinologist missed cases warranting ophthalmological
assessment.  In this way it was hoped that the referral system
might be improved to prevent avoidable vision loss.
Materials and methods 
Diabetic patients attending the specialist diabetic clinic at
Johannesburg Hospital had either one or both pupils dilated
(tropicamide or cyclopentolate) during a routine clinic visit. A
Canon CF-60 UV 60° fundus camera (35 mm colour
transparency film) was used to perform mydriatic fundus colour
photography centred on the macula. 
Of the 1 595 patients screened, acceptable photographs of at
least one eye were obtained for 1 517 patients (95.1%). In some
patients insufficiently dilated pupils, cataracts or poor patient
co-operation resulted in suboptimal photographic quality, which
was not acceptable for screening purposes (more than 50% of the
field was unreadable). 
Each fundus photograph was scored according to a
modification of the method of Davis et al.9 (Table I) by an
experienced endocrinologist/specialist physician (WJK). Three
levels of retinopathy were defined: none (level 10), mild to
moderate non-proliferative retinopathy (levels 20 and 30), and
severe retinopathy (retinal score of 35 or higher). Patients with
severe retinopathy were judged to warrant referral to the
ophthalmology outpatient department for further assessment
and possible treatment. The group included severe non-
proliferative retinopathy, preproliferative and proliferative
retinopathy, and maculopathy recognised as hard exudates
within two disc diameters of the centre of the fovea. 
During the present study, fundus photographs were reviewed
over a 5-day period by two experienced consultant ophthal-
mologists (TRC and NDW) who viewed and scored the
photographs independently of each other using the same criteria
used by the endocrinologist. The slides were reviewed in a
darkened room and projected to a size of about 2 m.
Comparisons between the scores of the endocrinologist and the
ophthalmologists were then made using the kappa statistic of
agreement. For this statistic, 0.0 is poor agreement, 0 - 0.2 is
slight, 0.21 - 0.4 is fair, 0.41 - 0.6 is moderate, 0.61 - 0.8 is
substantial and 0.81 - 1.0 is almost perfect agreement.10
Statistical analysis was performed using Stata version 8
software, Stata Corporation (College Station, Texas, USA).
Where appropriate, a combined score of the highest score for the
patient or eye by either ophthalmologist (gold standard) was
used in the analysis to try to ascertain the ‘true’ retinal score for
each eye or patient. This gold standard reference  was used to
reflect the worst possible score that the eye or patient might have
had to give a combination of the gradings by the two
ophthalmologists. Sensitivity and specificity were calculated
according to the method described by Altman and Bland.11
Demographic data and data pertaining to duration of diabetes
(at the time of presentation to the clinic) and age of onset of
diabetes were recorded and are reported, although they did not
influence the main objective of the study which was to ascertain
whether an experienced endocrinologist could use the fundus
photographs to screen accurately for diabetic retinopathy.
Results
Fifteen hundred and seventeen patients were included in the
study. There were 2 446 eyes, of which 1 122 were right eyes and
1 324 left eyes. Nine hundred and twenty-nine patients (61.2%)
had acceptable photographs of both eyes while 588 patients had
acceptable photographs of only one eye.  
The prevalence of any retinopathy as determined by the
endocrinologist was 33.4% (507 patients). This was in com-
parison to 26.5% (402 patients), the highest score given to
patients by the ophthalmologists. The prevalence of severe
retinopathy was 11.7% (177 patients, endocrinologist) and 12.6%
(191 patients, gold standard). The endocrinologist reported
significantly more retinopathy than the combined ophthal-
mologists (two-sample test of proportion, p = 0.0000). However,
Table I. Classification of diabetic retinopathy for retinal
photographs
Score Level of retinopathy
10 No retinopathy
20 Microaneurysms only (less than 20)
30 Microaneurysms 50 or less, haemorrhages 10 or less,
hard exudates 5 or less and small, not near macula, 
questionable soft exudates, questionable IRMAs,
questionable venous beading, definite venous loops
35 Hard exudates, 5 or less and small, within 2 disc
diameters of macular centre
40 Microaneurysms > 50, haemorrhages > 10, hard
exudates
not near macula, definite soft exudates, definite IRMAs,
definite venous beading
45 Hard exudates > 5 and/or larger, within 2 disc 
diameters
of macular centre
50 As for score 40 but more severe and including at least
3 of: (i) microaneurysms 10 - 20 and haemorrhages 
5 - 10; (ii) soft exudates > 2; (iii) definite IRMAs > 4
small areas
or  > 2 large areas; and (iv) venous beading > 2 veins 
60 Neovascularisation, laser burns, score > level 50, may
include macular oedema
IRMAs = intra-retinal microvascular abnormalities.
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the difference between endocrinologist and ophthalmologists on
severe retinopathy showed no significant difference. The
difference in diagnosis of any retinopathy was due to an
additional 99 patients with isolated microaneurysms (score 20)
diagnosed by the endocrinologist but not seen/agreed on by the
ophthalmologists.
As differences in prevalence have been reported for patients
from different ethnic groups,8 patients were stratified ethnically
for comparison of demographic data (Table II).
The proportion of males was significantly different for the
ethnic groups. There were significantly fewer black men at the
clinic compared with whites. There were 44.6% men in the black
group versus 57.8% in the white group (p = 0.0000, two-sample
test of proportion). The proportion of men was not different for
Indians (50.1%) versus whites (p = 0.0829) or for blacks versus
Indians (p = 0.1612).
There were significant age differences between ethnic groups
in the clinic, with the mean age for black patients of 45.8 years
being lower than that for Indians (mean 48.4, p = 0.0055,
Student’s t-test) and whites (mean 48.5, p = 0.0004, Student’s t-
test). There was no significant difference between the ages of
whites and Indians.
Age at diagnosis of diabetes was significantly higher for
blacks (mean age 41.9 years, confidence interval (CI): 41.0 - 42.9)
than for whites (mean 38.8 years, CI: 37.6 - 40.1) using the
Student’s t-test (p = 0.0003). There was no significant difference
between the age of Indians (mean 40.9 years, CI: 39.08 - 42.75)
and that of either blacks or whites.
The reported duration of diabetes differed by ethnic group,
with the shortest duration in blacks (mean 4.2 years). This was
significantly less (p = 0.0000, Student’s t-test) than the duration
in whites (mean 9.6 years) and Indians (mean 7.5 years). There
was also a significant difference between duration in white  and
Indian patients (p = 0.0115, Student’s t-test).
Compared with whites and Indians, blacks had significantly
less retinopathy as scored by the endocrinologist (24.3%) and the
combination of the highest scores given by either
ophthalmologist (gold standard) viz. 20.1%. These differences
were significant for the assessments by the endocrinologist
using two-sample proportion tests of blacks versus whites 
(p = 0.0000) and blacks versus Indians (p = 0.0004). There was no
significant difference between Indians and whites. Using the
proportions scored on the gold standard there was again
significantly less retinopathy in blacks than whites (p = 0.0000)
and Indians (p = 0.0193). 
From Table II it can be seen that the proportions of each ethnic
group with severe retinopathy was about 12% with no
significant differences between groups. 
Among patients with any retinopathy, severe retinopathy was
commonest in black patients, with 58.6% of patients needing
referral (Table III). This figure was significantly higher than for
whites (two-sample test of proportions, p = 0.0050), 42.3% of
whom needed referral. Indian patients, with 54.4% severity, did
not differ from either whites or blacks. Generally the proportion
of patients with severe retinopathy increased with increasing
duration of diabetes.
Patients were either referred or not referred based on the
retinal score for one or two eyes. When the patient score for the
endocrinologist was compared with the highest patient score for
either ophthalmologist, this showed an agreement of 80.1%,
with a kappa score of 0.59 showing moderate agreement. When
the patients referred by the endocrinologist fell into the severe
group, agreement between the endocrinologist and ophthal-
mologists was ‘almost perfect’ (agreement 96.6% with a kappa
value of 0.84).
The endocrinologist referred 177/1 517 (11.7%) of the patients
evaluated (Table IV). One or both ophthalmologists determined
that 191 patients needed referral (12.6%).
There was a false-positive rate of 1.25% (19/1 517 patients).
Neither ophthalmologist thought referral of these 19 patients
Table II. Characteristics of diabetic clinic patients by ethnic group 
Black White Indian
Number of patients (%) 588 (39) 739 (49) 180 (12)
Percentage of males in the group* 44.6 57.8 50.1
Mean age in years (CI)* 45.8 (44.9 - 46.7) 48.5 (47.3 - 49.6) 48.4 (46.7 - 50.1)
Mean age (years) at diagnosis (CI)* 41.91 ( 40.9 - 42.9) 38.80 (37.6 - 40.1) 40.91 (39.1 - 42.8)
Mean duration (years) of diabetes (CI)* 4.19 (3.5 - 4.8) 9.64 (8.9 - 10.4) 7.47 (6.2 - 8.8)
Prevalence of any retinopathy (%)
CE* 24.3 39.4 37.8
Gold standard* 20.1 30.7 28.3
Severe retinopathy (score > 30) (%)
CE 11.4 12.0 11.7
Gold standard 11.4 13.0 15.0
*Statistically significant difference. 
CE = consultant endocrinologist; gold standard = the highest score given by either ophthalmologist.
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was necessary. Of more concern was the 2.2% false-negative rate
(33/1 517 patients) where at least one of the ophthalmologists
thought the case should have been referred. In 8 cases, both
ophthalmologists thought a referral was necessary. There was
therefore also a difference of opinion between ophthalmologists
on referral in 25 of the cases. 
This gave a sensitivity for screening by the endocrinologist of
83%, so some cases were not referred which were thought to
require referral, and a specificity of 99% (if the endocrinologist
did not refer, the ophthalmologists almost always agreed).
Of the 33 false-negative cases that were not referred, 24 (73%)
had exudates in the macula and a further 7 (21%) had either new
vessels or laser burns.
Discussion 
The prevalence of retinopathy in the diabetic clinic was
approximately 30%, but only about 12% of patients screened
were of a severity requiring referral.
There was excellent agreement between the endocrinologist
and the ophthalmologists on which cases required referral. This
was measured at 97% agreement (kappa value of 0.84). The
agreement between screener and reviewers with regard to
presence or absence of any retinopathy was less impressive (80%
agreement, kappa value of 0.59). The difference was mostly in
patients where microaneurysms only were present, with the
screener tending to ‘overdiagnose’ isolated microaneurysms.
This effect might have resulted from differences in viewing
methods as the reviewers viewed the slides projected onto a
screen at a rate of about 500 slides per day. Ophthalmologists
screening a large number of slides over a short time period
might be more inclined to scan quickly for pathology and in this
way ‘underreport’ isolated microaneurysms. Since these cases
were not referable, it was not an important difference.
The baseline level of diabetic retinopathy has been found to
predict the prognosis and those with certain high-risk features
are at very high risk of blindness.12,13 In the Early Treatment
Diabetic Retinopathy Study,12 intraretinal microvascular
abnormalities (IRMAs), haemorrhages and microaneurysms,
and venous beading were found to be the most important
predictors of progression to proliferative retinopathy. Severe
vision loss (or vitrectomy) was found to follow the development
of high-risk proliferative retinopathy,13 as might be expected. For
type 2 diabetics, if the patient had retinopathy restricted to
microaneurysms, only 2 - 3% progressed to laser treatment
within 9 years.14 The authors found that if there was more than
microaneurysms only, about one-third progress to require laser
treatment by 12 years. Provided that they are referred, most
patients with early retinopathy can be followed up annually
should any sign of severity develop. 
Within the clinic the race groups differed somewhat, with
significantly more females among black patients. Black patients
were significantly younger than the Indian and white patients.
Some of these differences might be caused by socio-economic
factors and might also reflect historical use of the clinic mainly
by white patients in years gone by. The younger working black
male might still have to access health care closer to his place of
work, causing a difference in clinic distribution. 
Age at diagnosis was significantly higher for black patients;
this might reflect late diagnosis in this group or a greater
proportion of type 2 diabetes. The duration of diabetes was
shorter in black patients and this might also support late
diagnosis in this group. The lower prevalence of retinopathy in
blacks does not correlate with the more severe retinopathy seen
Table III. Number of patients with diabetic retinopathy and severe retinopathy by ethnic origin and duration of diabetes (years)
Black White Indian
Duration of Severe (as a % of Severe (as a % of Retinopathy* Severe (as a % of
diabetes (yrs) Retinopathy* retinopathy) Retinopathy* retinopathy) retinopathy)
< 1 16 8 50.0 7 1 14.3 6 2 33.3 
1 - 4 38 20 52.6 22 5 22.7 8 1 12.5 
5 - 8 21 11 52.4 29 12 41.4 5 2 40 
9 - 12 11 9 81.8 43 13 30.2 6 5 83.3 
13 - 20 20 13 65.0 60 32 53.3 10 5 50 
> 20 5 4 80.0 61 31 50.8 11 10 90.9 
Total 111   65 (58.6 ) 222 94 (42.3) 46 25 (54.4)
*Any diabetic retinopathy.
Table IV. Patients assessed as requiring referral by the highest
rating from the consultant endocrinologist (CE) and consultant
ophthalmologists (gold standard) 
Referral No referral
(gold standard) (gold standard)
Referral (CE) 158 19† 177
No referral (CE) 33* 1 307 1 340




in most age groups in blacks when compared with the two other
ethnic groups. This could be owing to a lower rate of isolated
microaneurysm detection because of the darker pigmented
fundus in the black subgroup, which may make it more difficult
to identify microaneurysms in these patients. 
Despite these differences, the screening method described
gave a sensitivity of 83% and a specificity of 99%. This satisfies
the British Diabetic Association standards of at least 80%
sensitivity and 95% specificity for screening methods.15
This study confirms the accuracy of the screening method
used at Johannesburg Hospital. Fundus photographs proved a
sensitive method of screening and most patients requiring
referral were accurately referred. There was a problem with the
interpretation of maculopathy. Health care personnel should be
aware of the need to refer patients with hard exudates near the
fovea as this might require laser treatment to prevent vision loss.
The results of this study support continued annual screening
with mydriatic fundus photographs to determine which patients
require referral to the ophthalmology clinic. 
A similar strategy might be applicable in other areas of the
country and could be applied by a range of suitable health care
personnel, including adequately trained nursing staff, optome-
trists and general practitioners. If the referral base for diabetic
patients is extended, preventable blindness might be avoided by
early referral of patients requiring treatment.
References
1. Garvican L, Clowes J, Gillow T. Preservation of sight in diabetes: developing a national risk
reduction programme. Diabet Med 2000; 17: 627-634.
2. Richter B, Kohner E. Medical interventions for diabetic retinopathy. In: Wormald R, Smeeth
L, Henshaw K, eds. Evidence-based Ophthalmology. London: BMJ Books, 2004: 331-338.
3. Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of
photography and direct ophthalmoscopy in screening for sight threatening eye disease: the
Liverpool diabetic eye study. BMJ 1995; 311: 1131-1135.
4. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy
from stereoscopic color fundus photographs — an extension of the modified Airlie House
classification. ETDRS report number 10. Ophthalmology 1991; 98: 786-806.
5. Wilkinson CP, Ferris FL III, Klein RE, et al. representing the Global Diabetic Retinopathy
Project Group. Proposed international clinical diabetic retinopathy and diabetic macular
edema disease severity scales. Ophthalmology 2003; 110: 1677-1682.
6. Mollentze WF, Stulting AA, Steyn AF. Ophthalmoscopy versus non-mydriatic fundus
photography in the detection of diabetic retinopathy in black patients. S Afr Med J 1990: 78:
248-250.
7. Joannou J, Kalk WJ, Mahomed I, et al. Screening for diabetic retinopathy in South Africa
with 60 retinal colour photography. J Intern Med 1996; 239: 43-47.
8. Kalk WJ, Joannou J, Ntsepo S, Mahomed I, Mahanlal P, Becker PJ. Ethnic differences in the
clinical and laboratory associations with retinopathy in adult onset diabetes: studies in
patients of African, European and Indian origins. J Intern Med 1997; 241: 31-37.
9. Davis MD, Hubbard LD, Trautman J, Klein R for the KROC collaborative study group.
Studies of retinopathy. Methodology for assessment and classification with fundus
photographs. Diabetes 1985; 34: (Suppl. 3), 42-49.
10. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics
1977; 33: 159-174.
11. Altman DG, Bland JM. Diagnostic tests 1: sensitivity and specificity. BMJ 1994; 308: 1552.
12. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk
factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991;
98: Suppl., 823-833.
13. Davis MD, Fisher MR, Gangnon RE, et al. for the Early Treatment Diabetic Retinopathy Study
Research Group. Risk factors for high-risk proliferative diabetic retinopathy and severe
visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci
1998; 39: 233-252.
14. Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR; UK Prospective Diabetes
Study (UKPDS) Group. Relationship between the severity of retinopathy and progression to
photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet
Med 2001; 18: 178-184.
15. British Diabetic Association. Retinal Photography Screening for Diabetic Eye Disease. A British
Diabetic Association Report. London: British Diabetic Association, 1997.
Accepted 23 August 2003.
61
January 2005, Vol. 95, No. 1  SAMJ
